HALOZYME THERAPEUTICS, INC. Logo

HALOZYME THERAPEUTICS, INC.

Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.

HALO | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
12390 EL CAMINO REAL, 92130 SAN DIEGO
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Halozyme Therapeutics, Inc. is a biotechnology company focused on its proprietary drug delivery technology platform, ENHANZE®. This technology facilitates the subcutaneous (under-the-skin) delivery of injectable drugs and biologics that are often administered intravenously. Halozyme licenses its ENHANZE® technology to global biopharmaceutical companies, enabling them to develop new formulations of their therapies. This model aims to reinvent the patient experience by reducing treatment burden and shortening administration times, particularly in therapeutic areas such as oncology. The company's commercial portfolio is primarily built on royalties and milestone payments derived from its partners' sales of products utilizing the ENHANZE® platform.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HALOZYME THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HALOZYME THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HALOZYME THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
CHAMPIONS ONCOLOGY, INC. Logo
Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.
United States of America CSBR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Logo
Global CRO for pharma & biotech, offering research models, safety testing & manufacturing solutions.
United States of America CRL
Ch. Charilaou Group Plc Logo
A tour operator selling travel packages and developing online reservation platform solutions.
Cyprus CHCH
Creates data-driven, integrated marketing and connected experiences for global brands.
South Korea 030000
Chiome Bioscience Inc. Logo
Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.
Japan 4583
Chordia Therapeutics,Inc Logo
Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.
Japan 190A
CHOSA Oncology AB Logo
Develops diagnostics and targeted therapies to personalize platinum-based cancer treatments.
Sweden CHOSA
Cidara Therapeutics, Inc. Logo
Developing drug-Fc conjugates as targeted immunotherapies for cancer and serious infections.
United States of America CDTX
CINC Corp. Logo
Offers AI marketing analytics and SEO tools leveraging a vast Japanese keyword dataset.
Japan 4378
CIRCULATION Co.,Ltd. Logo
Connects corporations with experts for project-based consulting to solve business challenges.
Japan 7379

Talk to a Data Expert

Have a question? We'll get back to you promptly.